Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Discover the key items to track in a monthly budget, from income to variable expenses, to ensure you meet your financial targets.
17,687 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A tech giant lanes three high-margin engines—cloud, ads, and subscriptions—on a profitable retail base, challenging m...
Public spaces near Hoboken Terminal have seen a troubling spike in phone-based scams. This guide breaks down how the ...
Yum! Brands is selling Pizza Hut in two moves, reshaping its portfolio. This could boost balance sheet strength and s...
A Seattle federal judge has ordered arbitration in the consolidated RESPA case against Zillow, pausing the lawsuit wh...
Two very different corners of the consumer space compete for attention in 2026: fashion-forward American Eagle Outfit...
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...
SpaceX is expanding fast after its IPO, but new debt plans and strategic bets raise questions for investors. This art...
SanDisk stock soared today as investors weighed memory-chip demand, rival earnings, and risk factors. This guide brea...
AI-driven data centers are reshaping memory supply. This article breaks down what data centers will consume for memor...
Ray Dalio’s Suez analogy returns to the headlines as markets weigh the U.S. risk of a reserve-currency shift and a we...
A leading analyst has reiterated a $250 SpaceX target, arguing that SpaceX's physical AI capabilities could reshape r...